Lonza’s Capsule Delivery Solutions, part of Lonza Pharma & Biotech, is launching Capsugel Vcaps Gen C, a high-quality capsule based on a carrageenan gelling-agent formulation. The new entry expands the Lonza Capsugel hydroxypropyl methyl cellulose (HPMC) portfolio. The launch of the high-performing, gelling agent-based capsule is the first since Lonza’s acquisition of Capsugel and part of the company’s business strategy to…

Lonza announced the expansion of its late-stage clinical and commercial encapsulation capabilities for solid oral and inhaled dosage forms in North America. The company will install a new Harro Hӧfliger Modu-C MS encapsulation unit (Harro unit) at its integrated product development and manufacturing facility in Tampa, FL to strengthen further its speed-to-market capabilities. The specialized drum-dosing technology is…